1. Home
  2. FOLD vs PAX Comparison

FOLD vs PAX Comparison

Compare FOLD & PAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FOLD
  • PAX
  • Stock Information
  • Founded
  • FOLD 2002
  • PAX 1988
  • Country
  • FOLD United States
  • PAX Cayman Islands
  • Employees
  • FOLD 499
  • PAX N/A
  • Industry
  • FOLD Biotechnology: Pharmaceutical Preparations
  • PAX Investment Managers
  • Sector
  • FOLD Health Care
  • PAX Finance
  • Exchange
  • FOLD Nasdaq
  • PAX Nasdaq
  • Market Cap
  • FOLD 2.5B
  • PAX 2.3B
  • IPO Year
  • FOLD 2007
  • PAX 2021
  • Fundamental
  • Price
  • FOLD $8.42
  • PAX $14.76
  • Analyst Decision
  • FOLD Strong Buy
  • PAX Strong Buy
  • Analyst Count
  • FOLD 9
  • PAX 1
  • Target Price
  • FOLD $26.44
  • PAX $14.00
  • AVG Volume (30 Days)
  • FOLD 5.3M
  • PAX 476.5K
  • Earning Date
  • FOLD 11-05-2025
  • PAX 11-04-2025
  • Dividend Yield
  • FOLD N/A
  • PAX 6.04%
  • EPS Growth
  • FOLD N/A
  • PAX N/A
  • EPS
  • FOLD N/A
  • PAX 0.53
  • Revenue
  • FOLD $571,160,000.00
  • PAX $397,386,000.00
  • Revenue This Year
  • FOLD $21.04
  • PAX N/A
  • Revenue Next Year
  • FOLD $21.34
  • PAX $19.89
  • P/E Ratio
  • FOLD N/A
  • PAX $27.15
  • Revenue Growth
  • FOLD 25.35
  • PAX 26.48
  • 52 Week Low
  • FOLD $5.51
  • PAX $9.43
  • 52 Week High
  • FOLD $12.65
  • PAX $15.54
  • Technical
  • Relative Strength Index (RSI)
  • FOLD 57.84
  • PAX 58.12
  • Support Level
  • FOLD $7.87
  • PAX $14.27
  • Resistance Level
  • FOLD $8.49
  • PAX $14.81
  • Average True Range (ATR)
  • FOLD 0.37
  • PAX 0.35
  • MACD
  • FOLD -0.03
  • PAX 0.01
  • Stochastic Oscillator
  • FOLD 81.67
  • PAX 95.84

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

About PAX Patria Investments Limited

Patria Investments Ltd is an alternative asset management firm specializing in resilient sectors across select regions. It seeks to provide world-wide and Latin American investors with attractive investment products that allows portfolio diversification and consistent returns. The group promotes inclusive and sustainable development in the Asset Classes: Private Equity, Private Equity Solutions, Credit, Real Estate, Infrastructure, and Public Equities Main sectors: Agribusiness, Power & Energy, Healthcare, Logistics & Transportations, Food & Beverage and Digital & Tech Services Investment Regions.

Share on Social Networks: